<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36799225</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2095-8137</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>18</Day></PubDate></JournalIssue><Title>Zoological research</Title><ISOAbbreviation>Zool Res</ISOAbbreviation></Journal><ArticleTitle>C9orf72 poly-GA proteins impair neuromuscular transmission.</ArticleTitle><Pagination><StartPage>331</StartPage><EndPage>340</EndPage><MedlinePgn>331-340</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24272/j.issn.2095-8137.2022.356</ELocationID><ELocationID EIdType="pii" ValidYN="Y">2095-8137(2023)02-0331-10</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a devastating motoneuron disease, in which lower motoneurons lose control of skeletal muscles. Degeneration of neuromuscular junctions (NMJs) occurs at the initial stage of ALS. Dipeptide repeat proteins (DPRs) from G4C2 repeat-associated non-ATG (RAN) translation are known to cause C9orf72-associated ALS (C9-ALS). However, DPR inclusion burdens are weakly correlated with neurodegenerative areas in C9-ALS patients, indicating that DPRs may exert cell non-autonomous effects, in addition to the known intracellular pathological mechanisms. Here, we report that poly-GA, the most abundant form of DPR in C9-ALS, is released from cells. Local administration of poly-GA proteins in peripheral synaptic regions causes muscle weakness and impaired neuromuscular transmission <i>in vivo</i>. The NMJ structure cannot be maintained, as evidenced by the fragmentation of postsynaptic acetylcholine receptor (AChR) clusters and distortion of presynaptic nerve terminals. Mechanistic study demonstrated that extracellular poly-GA sequesters soluble Agrin ligands and inhibits Agrin-MuSK signaling. Our findings provide a novel cell non-autonomous mechanism by which poly-GA impairs NMJs in C9-ALS. Thus, targeting NMJs could be an early therapeutic intervention for C9-ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tu</LastName><ForeName>Wen-Yo</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Zhejiang Provincial Key Laboratory of Pancreatic Disease, Department of Neurobiology, First Affiliated Hospital, Institute of Translational Medicine, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Wentao</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Zhejiang Provincial Key Laboratory of Pancreatic Disease, Department of Neurobiology, First Affiliated Hospital, Institute of Translational Medicine, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jianmin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Zhejiang Provincial Key Laboratory of Pancreatic Disease, Department of Neurobiology, First Affiliated Hospital, Institute of Translational Medicine, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Shuyuan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Zhejiang Provincial Key Laboratory of Pancreatic Disease, Department of Neurobiology, First Affiliated Hospital, Institute of Translational Medicine, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Zhejiang Provincial Key Laboratory of Pancreatic Disease, Department of Neurobiology, First Affiliated Hospital, Institute of Translational Medicine, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Chengyong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Zhejiang Provincial Key Laboratory of Pancreatic Disease, Department of Neurobiology, First Affiliated Hospital, Institute of Translational Medicine, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310020, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MOE Frontier Science, Center for Brain Research and Brain-Machine Integration, Zhejiang University, Hangzhou, Zhejiang 310058, China. E-mail: cshen@zju.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kejing</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Zhejiang Provincial Key Laboratory of Pancreatic Disease, Department of Neurobiology, First Affiliated Hospital, Institute of Translational Medicine, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310020, China. E-mail: kjzhang@zju.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zool Res</MedlineTA><NlmUniqueID>101697192</NlmUniqueID><ISSNLinking>2095-8137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018171">Agrin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018171" MajorTopicYN="N">Agrin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText>&#x808c;&#x840e;&#x7f29;&#x6027;&#x4fa7;&#x7d22;&#x786c;&#x5316;&#x75c7; (ALS) &#x662f;&#x4e00;&#x79cd;&#x81f4;&#x6b7b;&#x6027;&#x7684;&#x8fd0;&#x52a8;&#x795e;&#x7ecf;&#x5143;&#x9000;&#x884c;&#x6027;&#x75be;&#x75c5;&#xff0c;&#x75c5;&#x4eba;&#x7684;&#x8fd0;&#x52a8;&#x795e;&#x7ecf;&#x5143;&#x9010;&#x6e10;&#x75c5;&#x53d8;&#x6b7b;&#x4ea1;&#xff0c;&#x5bfc;&#x81f4;&#x65e0;&#x6cd5;&#x63a7;&#x5236;&#x9aa8;&#x9abc;&#x808c;&#x3002;&#x795e;&#x7ecf;&#x808c;&#x8089;&#x63a5;&#x5934;(NMJ)&#x662f;&#x8fd0;&#x52a8;&#x795e;&#x7ecf;&#x5143;&#x4e0e;&#x9aa8;&#x9abc;&#x808c;&#x4e4b;&#x95f4;&#x7684;&#x7a81;&#x89e6;&#x8fde;&#x63a5;&#xff0c;&#x5176;&#x9000;&#x5316;&#x5728;ALS&#x7684;&#x521d;&#x59cb;&#x9636;&#x6bb5;&#x5c31;&#x5f00;&#x59cb;&#x53d1;&#x751f;&#x3002;&#x7b2c;&#x4e5d;&#x53f7;&#x67d3;&#x8272;&#x4f53;C9orf72&#x57fa;&#x56e0;&#x7684;&#x5185;&#x542b;&#x5b50;&#x533a;&#x57df;GGGGCC&#x7684;&#x5f02;&#x5e38;&#x91cd;&#x590d;&#xff0c;&#x662f;&#x5bfc;&#x81f4;ALS&#x7684;&#x6700;&#x4e3b;&#x8981;&#x9057;&#x4f20;&#x56e0;&#x7d20;&#x3002;GGGGCC&#x91cd;&#x590d;&#x80fd;&#x591f;&#x4e0d;&#x4f9d;&#x8d56;ATG&#x7ffb;&#x8bd1;&#x542f;&#x52a8;&#x5b50;&#xff0c;&#x4ea7;&#x751f;&#x6bd2;&#x6027;&#x7684;&#x4e8c;&#x80bd;&#x91cd;&#x590d;&#x86cb;&#x767d;(DPR)&#xff0c;&#x5176;&#x4e2d;&#x591a;&#x805a;&#x7518;&#x6c28;&#x9178;-&#x4e19;&#x6c28;&#x9178;&#x91cd;&#x590d;&#x591a;&#x80bd;&#x86cb;&#x767d;&#xff08;poly-GA&#xff09;&#x662f;&#x75c5;&#x4eba;&#x4e2d;&#x542b;&#x91cf;&#x6700;&#x9ad8;&#x7684;DPR&#x3002;&#x6211;&#x4eec;&#x53d1;&#x73b0;&#x5728;&#x808c;&#x8089;&#x7a81;&#x89e6;&#x5c40;&#x90e8;&#x6ce8;&#x5c04;poly-GA&#x86cb;&#x767d;&#xff0c;&#x4f1a;&#x5bfc;&#x81f4;&#x808c;&#x8089;&#x65e0;&#x529b;&#x5e76;&#x635f;&#x5bb3;&#x795e;&#x7ecf;&#x808c;&#x8089;&#x7684;&#x4fe1;&#x606f;&#x4f20;&#x9012;&#xff0c;&#x540c;&#x65f6;&#x8fd8;&#x5f71;&#x54cd;&#x4e86;NMJ&#x7ed3;&#x6784;&#x7684;&#x7ef4;&#x6301;&#x3002;&#x6211;&#x4eec;&#x8fdb;&#x4e00;&#x6b65;&#x53d1;&#x73b0;poly-GA&#x4f1a;&#x7ed3;&#x5408;&#x51dd;&#x96c6;&#x7d20;Agrin&#xff0c;&#x8fdb;&#x800c;&#x6291;&#x5236;Agrin-MuSK&#x4fe1;&#x53f7;&#x901a;&#x8def;&#xff0c;&#x4ece;&#x800c;&#x5bfc;&#x81f4;&#x4e59;&#x9170;&#x80c6;&#x78b1;&#x53d7;&#x4f53;&#x89e3;&#x805a;&#x3002;&#x6211;&#x4eec;&#x7684;&#x7814;&#x7a76;&#x8bf4;&#x660e;poly-GA&#x53ef;&#x4ee5;&#x901a;&#x8fc7;&#x7ec6;&#x80de;&#x975e;&#x81ea;&#x4e3b;&#x673a;&#x5236;&#x6765;&#x635f;&#x5bb3;NMJ&#x548c;&#x8fd0;&#x52a8;&#x529f;&#x80fd;&#xff0c;&#x9488;&#x5bf9;C9-ALS&#x7684;NMJ&#x65e9;&#x671f;&#x9776;&#x5411;&#x6cbb;&#x7597;&#x5e72;&#x9884;&#x53ef;&#x80fd;&#x662f;&#x4e00;&#x4e2a;&#x6709;&#x524d;&#x666f;&#x7684;&#x65b9;&#x5411;&#x3002;.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Agrin</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Neuromuscular junction</Keyword><Keyword MajorTopicYN="N">Poly-Gly-Ala</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>17</Day><Hour>5</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36799225</ArticleId><ArticleId IdType="pmc">PMC10083233</ArticleId><ArticleId IdType="doi">10.24272/j.issn.2095-8137.2022.356</ArticleId><ArticleId IdType="pii">2095-8137(2023)02-0331-10</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arimura S, Okada T, Tezuka T, et al DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction. Science. 2014;345(6203):1505&#x2013;1508. doi: 10.1126/science.1250744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1250744</ArticleId><ArticleId IdType="pubmed">25237101</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai L, Tu WY, Xiao YT, et al Motoneurons innervation determines the distinct gene expressions in multinucleated myofibers. Cell &amp; Bioscience. 2022;12(1):140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9429338</ArticleId><ArticleId IdType="pubmed">36042463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentzinger CF, Barzaghi P, Lin S, et al Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-&#x3b1;2-deficient mice. The FASEB Journal. 2005;19(8):934&#x2013;942. doi: 10.1096/fj.04-3376com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.04-3376com</ArticleId><ArticleId IdType="pubmed">15923403</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertrand A, Wen J, Rinaldi D, et al Early cognitive, structural, and microstructural changes in presymptomatic C9orf72 Carriers younger than 40 years. JAMA Neurology. 2018;75(2):236&#x2013;245. doi: 10.1001/jamaneurol.2017.4266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.4266</ArticleId><ArticleId IdType="pmc">PMC5838615</ArticleId><ArticleId IdType="pubmed">29197216</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezakova G, Ruegg MA New insights into the roles of agrin. Nature Reviews Molecular Cell Biology. 2003;4(4):295&#x2013;309. doi: 10.1038/nrm1074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm1074</ArticleId><ArticleId IdType="pubmed">12671652</ArticleId></ArticleIdList></Reference><Reference><Citation>Brahic M, Bousset L, Bieri G, et al Axonal transport and secretion of fibrillar forms of &#x3b1;-synuclein, A&#x3b2;42 peptide and HTTExon 1. Acta Neuropathologica. 2016;131(4):539&#x2013;548. doi: 10.1007/s00401-016-1538-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1538-0</ArticleId><ArticleId IdType="pmc">PMC4789229</ArticleId><ArticleId IdType="pubmed">26820848</ArticleId></ArticleIdList></Reference><Reference><Citation>Burden SJ, Yumoto N, Zhang W The role of MuSK in synapse formation and neuromuscular disease. Cold Spring Harbor Perspectives in Biology. 2013;5(5):a009167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3632064</ArticleId><ArticleId IdType="pubmed">23637281</ArticleId></ArticleIdList></Reference><Reference><Citation>Chand KK, Lee KM, Lee JD, et al Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP-43Q331K transgenic mouse model of amyotrophic lateral sclerosis. The FASEB Journal. 2018;32(5):2676&#x2013;2689. doi: 10.1096/fj.201700835R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201700835R</ArticleId><ArticleId IdType="pubmed">29295857</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YJ, Jeng US, Chiang YL, et al The glycine-alanine dipeptide repeat from C9orf72 hexanucleotide expansions forms toxic amyloids possessing cell-to-cell transmission properties. Journal of Biological Chemistry. 2016;291(10):4903&#x2013;4911. doi: 10.1074/jbc.M115.694273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.694273</ArticleId><ArticleId IdType="pmc">PMC4777828</ArticleId><ArticleId IdType="pubmed">26769963</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen AZ, Bai L, Zhong KK, et al APC2CDH1 negatively regulates agrin signaling by promoting the ubiquitination and proteolytic degradation of DOK7. The FASEB Journal. 2020;34(9):12009&#x2013;12023. doi: 10.1096/fj.202000485R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202000485R</ArticleId><ArticleId IdType="pubmed">32687671</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleary JD, Ranum LPW New developments in RAN translation: insights from multiple diseases. Current Opinion in Genetics &amp; Development. 2017;44:125&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5951168</ArticleId><ArticleId IdType="pubmed">28365506</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores BN, Dulchavsky ME, Krans A, et al Distinct C9orf72-associated dipeptide repeat structures correlate with neuronal toxicity. PLoS One. 2016;11(10):e0165084. doi: 10.1371/journal.pone.0165084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0165084</ArticleId><ArticleId IdType="pmc">PMC5077081</ArticleId><ArticleId IdType="pubmed">27776165</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Lu YB, Lopez-Gonzalez R, et al GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525(7567):129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao FB, Almeida S, Lopez-Gonzalez R Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder. The EMBO Journal. 2017a;36(20):2931&#x2013;2950. doi: 10.15252/embj.201797568.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797568</ArticleId><ArticleId IdType="pmc">PMC5641681</ArticleId><ArticleId IdType="pubmed">28916614</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao FB, Richter JD, Cleveland DW Rethinking unconventional translation in neurodegeneration. Cell. 2017b;171(5):994&#x2013;1000. doi: 10.1016/j.cell.2017.10.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.10.042</ArticleId><ArticleId IdType="pmc">PMC5728172</ArticleId><ArticleId IdType="pubmed">29149615</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, Menon P, &#xd6;zdinler PH, et al Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nature Reviews Neurology. 2016;12(11):651&#x2013;661. doi: 10.1038/nrneurol.2016.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.140</ArticleId><ArticleId IdType="pubmed">27658852</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Chew J, Stankowski JN, et al Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis. Science Translational Medicine. 2017;9(383):eaai7866. doi: 10.1126/scitranslmed.aai7866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aai7866</ArticleId><ArticleId IdType="pmc">PMC5576451</ArticleId><ArticleId IdType="pubmed">28356511</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, van Blitterswijk M, Bieniek KF, et al Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers. Acta Neuropathologica. 2015;130(4):559&#x2013;573. doi: 10.1007/s00401-015-1474-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1474-4</ArticleId><ArticleId IdType="pmc">PMC4575385</ArticleId><ArticleId IdType="pubmed">26350237</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilhus NE, Skeie GO, Romi F, et al Myasthenia gravis - autoantibody characteristics and their implications for therapy. Nature Reviews Neurology. 2016;12(5):259&#x2013;268. doi: 10.1038/nrneurol.2016.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.44</ArticleId><ArticleId IdType="pubmed">27103470</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, Donnelly CJ, Rothstein JD The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease. Nature Reviews Neuroscience. 2016;17(6):383&#x2013;395. doi: 10.1038/nrn.2016.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2016.38</ArticleId><ArticleId IdType="pmc">PMC7376590</ArticleId><ArticleId IdType="pubmed">27150398</ArticleId></ArticleIdList></Reference><Reference><Citation>Herranz-Martin S, Chandran J, Lewis K, et al Viral delivery of C9orf72 hexanucleotide repeat expansions in mice leads to repeat-length-dependent neuropathology and behavioural deficits. Disease Models &amp; Mechanisms. 2017;10(7):859&#x2013;868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5536911</ArticleId><ArticleId IdType="pubmed">28550099</ArticleId></ArticleIdList></Reference><Reference><Citation>Hettwer S, Lin S, Kucsera S, et al Injection of a soluble fragment of neural agrin (NT-1654) considerably improves the muscle pathology caused by the disassembly of the neuromuscular junction. PLoS One. 2014;9(2):e88739. doi: 10.1371/journal.pone.0088739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0088739</ArticleId><ArticleId IdType="pmc">PMC3919806</ArticleId><ArticleId IdType="pubmed">24520420</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen BK, Schuldi MH, McAvoy K, et al Synaptic dysfunction induced by glycine-alanine dipeptides in C9orf72-ALS/FTD is rescued by SV2 replenishment. EMBO Molecular Medicine. 2020;12(5):e10722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7207170</ArticleId><ArticleId IdType="pubmed">32347002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim N, Stiegler AL, Cameron TO, et al Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell. 2008;135(2):334&#x2013;342. doi: 10.1016/j.cell.2008.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.10.002</ArticleId><ArticleId IdType="pmc">PMC2933840</ArticleId><ArticleId IdType="pubmed">18848351</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan G, Raitcheva D, Bartlett D, et al Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD. Nature Communications. 2022;13(1):2799. doi: 10.1038/s41467-022-30387-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30387-4</ArticleId><ArticleId IdType="pmc">PMC9119980</ArticleId><ArticleId IdType="pubmed">35589711</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YB, Baskaran P, Gomez-Deza J, et al C9orf72 poly GA RAN-translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity. Human Molecular Genetics. 2017;26(24):4765&#x2013;4777. doi: 10.1093/hmg/ddx350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx350</ArticleId><ArticleId IdType="pmc">PMC5886201</ArticleId><ArticleId IdType="pubmed">28973350</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Xiong WC, Mei L Neuromuscular junction formation, aging, and disorders. Annual Review of Physiology. 2018;80:159&#x2013;188. doi: 10.1146/annurev-physiol-022516-034255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-022516-034255</ArticleId><ArticleId IdType="pubmed">29195055</ArticleId></ArticleIdList></Reference><Reference><Citation>Li WY, Wang Y, Zhai FG, et al AAV-KLF7 promotes descending propriospinal neuron axonal plasticity after spinal cord injury. Neural Plasticity. 2017;2017:1621629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5572611</ArticleId><ArticleId IdType="pubmed">28884027</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YJ, Pattamatta A, Zu T, et al C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron. 2016;90(3):521&#x2013;534. doi: 10.1016/j.neuron.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Arzberger T, Kremmer E, et al Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathologica. 2013;126(6):859&#x2013;879. doi: 10.1007/s00401-013-1181-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1181-y</ArticleId><ArticleId IdType="pubmed">24096617</ArticleId></ArticleIdList></Reference><Reference><Citation>May S, Hornburg D, Schludi MH, et al C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathologica. 2014;128(4):485&#x2013;503. doi: 10.1007/s00401-014-1329-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1329-4</ArticleId><ArticleId IdType="pmc">PMC4159571</ArticleId><ArticleId IdType="pubmed">25120191</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyoshi S, Tezuka T, Arimura S, et al DOK7 gene therapy enhances motor activity and life span in ALS model mice. EMBO Molecular Medicine. 2017;9(7):880&#x2013;889. doi: 10.15252/emmm.201607298.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201607298</ArticleId><ArticleId IdType="pmc">PMC5494517</ArticleId><ArticleId IdType="pubmed">28490573</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney EB, De Winter F, Verhaagen J ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Frontiers in Neuroscience. 2014;8:252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretto E, Stuart S, Surana S, et al The role of extracellular matrix components in the spreading of pathological protein aggregates. Frontiers in Cellular Neuroscience. 2022;16:844211. doi: 10.3389/fncel.2022.844211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2022.844211</ArticleId><ArticleId IdType="pmc">PMC9100790</ArticleId><ArticleId IdType="pubmed">35573838</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Weng SM, Arzberger T, et al The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339(6125):1335&#x2013;1338. doi: 10.1126/science.1232927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L, Montrasio F, Pattamatta A, et al Antibody therapy targeting RAN proteins rescues C9 ALS/FTD phenotypes in C9orf72 mouse model. Neuron. 2020;105(4):645&#x2013;662.e11. doi: 10.1016/j.neuron.2019.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.11.007</ArticleId><ArticleId IdType="pmc">PMC7391607</ArticleId><ArticleId IdType="pubmed">31831332</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohno K, Ohkawara B, Ito M Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders. Expert Opinion on Therapeutic Targets. 2017;21(10):949&#x2013;958. doi: 10.1080/14728222.2017.1369960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2017.1369960</ArticleId><ArticleId IdType="pubmed">28825343</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Rourke JG, Bogdanik L, Y&#xe1;&#xf1;ez A, et al C9orf72 is required for proper macrophage and microglial function in mice. Science. 2016;351(6279):1324&#x2013;1329. doi: 10.1126/science.aaf1064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Garc&#xed;a MJ, Burden SJ Increasing MuSK activity delays denervation and improves motor function in ALS mice. Cell Reports. 2012;2(3):497&#x2013;502. doi: 10.1016/j.celrep.2012.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.08.004</ArticleId><ArticleId IdType="pmc">PMC3462266</ArticleId><ArticleId IdType="pubmed">22939980</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et al A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivner MH, Liu SY, Quarles B, et al Agrin and low-density lipoprotein-related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients. Muscle &amp; Nerve. 2017;55(3):430&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5318258</ArticleId><ArticleId IdType="pubmed">27756107</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez Cruz PM, Palace J, Beeson D Congenital myasthenic syndromes and the neuromuscular junction. Current Opinion in Neurology. 2014;27(5):566&#x2013;575. doi: 10.1097/WCO.0000000000000134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000134</ArticleId><ArticleId IdType="pubmed">25159927</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S, Stauffer JE, Jiang J, et al Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathologica. 2018;135(3):459&#x2013;474. doi: 10.1007/s00401-017-1793-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1793-8</ArticleId><ArticleId IdType="pmc">PMC5935138</ArticleId><ArticleId IdType="pubmed">29196813</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi MH, Becker L, Garrett L, et al Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss. Acta Neuropathologica. 2017;134(2):241&#x2013;254. doi: 10.1007/s00401-017-1711-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1711-0</ArticleId><ArticleId IdType="pmc">PMC5508040</ArticleId><ArticleId IdType="pubmed">28409281</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi MH, May S, Gr&#xe4;sser FA, et al Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing. Acta Neuropathologica. 2015;130(4):537&#x2013;555. doi: 10.1007/s00401-015-1450-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1450-z</ArticleId><ArticleId IdType="pmc">PMC4575390</ArticleId><ArticleId IdType="pubmed">26085200</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen CY, Chen YF, Liu HQ, et al Hydrogen peroxide promotes A&#x3b2; production through JNK-dependent activation of &#x3b3;-secretase. Journal of Biological Chemistry. 2008;283(25):17721&#x2013;17730. doi: 10.1074/jbc.M800013200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M800013200</ArticleId><ArticleId IdType="pmc">PMC2427353</ArticleId><ArticleId IdType="pubmed">18436531</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen CY, Li L, Zhao K, et al Motoneuron Wnts regulate neuromuscular junction development. eLife. 2018;7:e34625. doi: 10.7554/eLife.34625.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.34625</ArticleId><ArticleId IdType="pmc">PMC6128691</ArticleId><ArticleId IdType="pubmed">30113308</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen CY, Lu YS, Zhang B, et al Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis. The Journal of Clinical Investigation. 2013;123(12):5190&#x2013;5202. doi: 10.1172/JCI66039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI66039</ArticleId><ArticleId IdType="pmc">PMC3859418</ArticleId><ArticleId IdType="pubmed">24200689</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen CY, Xiong WC, Mei L LRP4 in neuromuscular junction and bone development and diseases. Bone. 2015;80:101&#x2013;108. doi: 10.1016/j.bone.2015.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2015.05.012</ArticleId><ArticleId IdType="pubmed">26071838</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu WY, Xu WT, Zhang KJ, et al Whole-mount staining of neuromuscular junctions in adult mouse diaphragms with a sandwich-like apparatus. Journal of Neuroscience Methods. 2021;350:109016. doi: 10.1016/j.jneumeth.2020.109016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2020.109016</ArticleId><ArticleId IdType="pubmed">33316317</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzartos JS, Zisimopoulou P, Rentzos M, et al LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients. Annals of Clinical and Translational Neurology. 2014;1(2):80&#x2013;87. doi: 10.1002/acn3.26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.26</ArticleId><ArticleId IdType="pmc">PMC4212481</ArticleId><ArticleId IdType="pubmed">25356387</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergard T, Jensen BK, Wen XM, et al Cell-to-cell transmission of dipeptide repeat proteins linked to C9orf72-ALS/FTD. Cell Reports. 2016;17(3):645&#x2013;652. doi: 10.1016/j.celrep.2016.09.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.09.032</ArticleId><ArticleId IdType="pmc">PMC5078984</ArticleId><ArticleId IdType="pubmed">27732842</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu HT, Xiong WC, Mei L To build a synapse: signaling pathways in neuromuscular junction assembly. Development. 2010;137(7):1017&#x2013;1033. doi: 10.1242/dev.038711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.038711</ArticleId><ArticleId IdType="pmc">PMC2835321</ArticleId><ArticleId IdType="pubmed">20215342</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao YT, Zhang JM, Shu XQ, et al Loss of mitochondrial protein CHCHD10 in skeletal muscle causes neuromuscular junction impairment. Human Molecular Genetics. 2020;29(11):1784&#x2013;1796. doi: 10.1093/hmg/ddz154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz154</ArticleId><ArticleId IdType="pubmed">31261376</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakawa M, Ito D, Honda T,et al Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS. Human Molecular Genetics. 2015;24(6):1630&#x2013;1645. doi: 10.1093/hmg/ddu576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu576</ArticleId><ArticleId IdType="pubmed">25398948</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Luo SW, Wang Q, et al LRP4 serves as a coreceptor of agrin. Neuron. 2008;60(2):285&#x2013;297. doi: 10.1016/j.neuron.2008.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2008.10.006</ArticleId><ArticleId IdType="pmc">PMC2743173</ArticleId><ArticleId IdType="pubmed">18957220</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Shen CY, Bealmear B, et al Autoantibodies to agrin in myasthenia gravis patients. PLoS One. 2014;9(3):e91816. doi: 10.1371/journal.pone.0091816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0091816</ArticleId><ArticleId IdType="pmc">PMC3954737</ArticleId><ArticleId IdType="pubmed">24632822</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Donnelly CJ, Haeusler AR, et al The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525(7567):56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang KJ, Wang AL, Zhong KK, et al UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model. Neuron. 2021;109(12):1949&#x2013;1962.e6. doi: 10.1016/j.neuron.2021.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.04.023</ArticleId><ArticleId IdType="pubmed">33991504</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Gendron TF, Grima JC, et al C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nature Neuroscience. 2016;19(5):668&#x2013;677. doi: 10.1038/nn.4272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4272</ArticleId><ArticleId IdType="pmc">PMC5138863</ArticleId><ArticleId IdType="pubmed">26998601</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao K, Shen CY, Lu YS, et al Muscle yap is a regulator of neuromuscular junction formation and regeneration. Journal of Neuroscience. 2017;37(13):3465&#x2013;3477. doi: 10.1523/JNEUROSCI.2934-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2934-16.2017</ArticleId><ArticleId IdType="pmc">PMC5373129</ArticleId><ArticleId IdType="pubmed">28213440</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Li J, Rosenbaum DM, et al The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits. PLoS One. 2017a;12(9):e0184049. doi: 10.1371/journal.pone.0184049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0184049</ArticleId><ArticleId IdType="pmc">PMC5589177</ArticleId><ArticleId IdType="pubmed">28880966</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou QH, Lehmer C, Michaelsen M, et al Antibodies inhibit transmission and aggregation of C9orf72 poly-GA dipeptide repeat proteins. EMBO Molecular Medicine. 2017b;9(5):687&#x2013;702. doi: 10.15252/emmm.201607054.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201607054</ArticleId><ArticleId IdType="pmc">PMC5412769</ArticleId><ArticleId IdType="pubmed">28351931</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, Gibbens B, Doty NS, et al Non-ATG-initiated translation directed by microsatellite expansions. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(1):260&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3017129</ArticleId><ArticleId IdType="pubmed">21173221</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>